Hideto Kameda

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Topics

Rheumatoid Arthritis

Top Venues

Modern rheumatology

International journal of rheumatic diseases

Rheumatology and therapy

Arthritis & rheumatology (Hoboken, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

Hideto Kameda, Sadatomo Tasaka, Toshiya Takahashi, Katsuhisa Suzuki, Naoki Soeda, Hubert van Hoogstraten, Remco Diab, Yoshiya Tanaka
Safety of sarilumab in a Japanese population with rheumatoid arthritis by age group: Data from an interim analysis of a post-marketing surveillance study. Modern rheumatology (2024)
Hideto Kameda
Methotrexate dosage and dosing in Japan. International journal of rheumatic diseases 27 (5) (2024)
Yoshiya Tanaka, Toshiya Takahashi, Hubert van Hoogstraten, Naoto Kato, Hideto Kameda
The effects of sarilumab as monotherapy and in combination with non-methotrexate disease-modifying anti-rheumatic drugs on unacceptable pain in patients with rheumatoid arthritis: a post-hoc analysis of the HARUKA phase 3 study. Modern rheumatology (2024)
Hideto Kameda, Kohei Hagimori, Yoji Morisaki, Thorsten Holzkämper, Ayako Konomi, Hiroaki Dobashi
Correction: Ixekizumab Efficacy in Patients with Severe Peripheral Psoriatic Arthritis: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (SPIRIT-P1). Rheumatology and therapy (2024)
Yoshiya Tanaka, Toshiya Takahashi, Hubert van Hoogstraten, Naoto Kato, Hideto Kameda
Efficacy and safety of sarilumab in patients with rheumatoid arthritis stratified by age (<65 and ≥65 years): A post-hoc analysis of Japanese phase 3 clinical trials. Modern rheumatology (2024)
Hideto Kameda, Kohei Hagimori, Yoji Morisaki, Thorsten Holzkämper, Ayako Konomi, Hiroaki Dobashi
Ixekizumab Efficacy in Patients with Severe Peripheral Psoriatic Arthritis: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (SPIRIT-P1). Rheumatology and therapy (2023)
Hideto Kameda, Kunihiro Yamaoka, Yuji Yamanishi, Masahiro Tada, Ryuji Koike, Ayako Nakajima, Mie Fusama, Takao Fujii
Japan College of Rheumatology guidance for the use of methotrexate in patients with rheumatoid arthritis: Secondary publication. Modern rheumatology (2023)
Yuko Kaneko, Hideto Kameda, Kei Ikeda, Katsuhisa Yamashita, Ryoto Ozaki, Yoshiya Tanaka
Treatment pattern and changes in oral glucocorticoid dose after tocilizumab treatment in patients with adult Still's disease: An analysis of a Japanese claims database. International journal of rheumatic diseases (2023)
Yasuyuki Todoroki, Yusuke Miyazaki, Koichi Amano, Kiyoshi Matsui, Hideto Kameda, Yoshino Inoue, Shingo Nakayamada, Takehisa Ogura, Yuko Kaneko, Kunihiro Yamaoka, Yoshiya Tanaka
Sustained remission following the discontinuation of tofacitinib in patients with rheumatoid arthritis (XANADU study): an open-label randomised study. RMD open 9 (2) (2023)
Hideto Kameda, Sadatomo Tasaka, Toshiya Takahashi, Katsuhisa Suzuki, Naoki Soeda, Yoshiya Tanaka
Safety and effectiveness of sarilumab in Japanese patients with rheumatoid arthritis refractory to previous treatments: An interim analysis of a post-marketing surveillance. Modern rheumatology (2023)
Désirée Mfm van der Heijde, Xenofon Baraliakos, Joachim Sieper, Atul A Deodhar, Robert D Inman, Hideto Kameda, Xiaofeng Zeng, Yunxia Sui, Xianwei Bu, Aileen L Pangan, Peter Wung, In-Ho Song
Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial. Annals of the rheumatic diseases 81 (11) (2022)
Keisuke Ono, Kishimoto Mitsumasa, Gautam A Deshpande, Sho Fukui, Satoshi Kawaai, Haruki Sawada, Minoru Matsuura, Valeria Rios Rodriguez, Fabian Proft, Kurisu Tada, Naoto Tamura, Yoshinori Taniguchi, Ayako Hirata, Hideto Kameda, Shigeyoshi Tsuji, Yuko Kaneko, Hiroaki Dobashi, Tadashi Okano, Yoichiro Haji, Akimichi Morita, Masato Okada, Yoshinori Komagata, Clementina López Medina, Anna Moltó, Maxime Dougados, Tadakazu Hisamatsu, Tetsuya Tomita, Shinya Kaname
Clinical characteristics of patients with spondyloarthritis and inflammatory bowel disease versus inflammatory bowel disease-related arthritis. Rheumatology international 42 (10) (2022)
Hideto Kameda, Mitsumasa Kishimoto, Shigeto Kobayashi, Tetsuya Tomita, Akimichi Morita, Masahiro Yamamura
Axial Spondyloarthritis in Japan. Current rheumatology reports 24 (5) (2022)
Hideto Kameda, Tsutomu Takeuchi, Kunihiro Yamaoka, Motohiro Oribe, Mitsuhiro Kawano, Masayuki Yokoyama, Aileen L Pangan, Yuko Konishi, Sebastian Meerwein, Yoshiya Tanaka
Efficacy and safety of upadacitinib over 84 weeks in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE). Arthritis research & therapy 23 (1) (2021)
Takehisa Ogura, Ayako Hirata, Norihide Hayashi, Chihiro Imaizumi, Hideki Ito, Sayaka Takenaka, Yuki Inoue, Yuto Takakura, Kennosuke Mizushina, Takaharu Katagiri, Hideto Kameda
Finger Joint Cartilage Evaluated by Semiquantitative Ultrasound Score in Patients With Rheumatoid Arthritis. Arthritis care & research 73 (2) (2021)
Laura C Coates, Sreekumar G Pillai, Hasan Tahir, Ivo Valter, Vinod Chandran, Hideto Kameda, Masato Okada, Lisa Kerr, Denise Alves, So Young Park, David H Adams, Gaia Gallo, Matthew M Hufford, Maja Hojnik, Philip J Mease, Arthur Kavanaugh, null null
Withdrawing Ixekizumab in Patients With Psoriatic Arthritis Who Achieved Minimal Disease Activity: Results From a Randomized, Double-Blind Withdrawal Study. Arthritis & rheumatology (Hoboken, N.J.) 73 (9) (2021)
Hideto Kameda, Ayako Hirata, Takaharu Katagiri, Yuto Takakura, Yuki Inoue, Sayaka Takenaka, Hideki Ito, Kennosuke Mizushina, Takehisa Ogura
Prediction of disease flare by biomarkers after discontinuing biologics in patients with rheumatoid arthritis achieving stringent remission. Scientific reports 11 (1) (2021)
Kunihiro Yamaoka, Yoshiya Tanaka, Hideto Kameda, Nasser Khan, Nobuhito Sasaki, Masayoshi Harigai, Yanna Song, Ying Zhang, Tsutomu Takeuchi
The Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis in Japan. Drug safety 44 (6) (2021)
Hideto Kameda, Eishi Uechi, Tatsuya Atsumi, Carlos Abud-Mendoza, Kazumasa Kamei, Tsugumi Matsumoto, Dario Ponce de Leon, Muhammad I Rehman, Min Zhang, Sebastiao C Radominski
A comparative study of PF-06438179/GP1111 (an infliximab biosimilar) and reference infliximab in patients with moderate to severe active rheumatoid arthritis: A subgroup analysis. International journal of rheumatic diseases 23 (7) (2020)
Atul A Deodhar, Ricardo Blanco, Eva Dokoupilová, Stephen Hall, Hideto Kameda, Alan J Kivitz, Denis Poddubnyy, Marleen van de Sande, Anna S Wiksten, Brian O Porter, Hanno B Richards, Sibylle Haemmerle, Jürgen Braun
Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III Study. Arthritis & rheumatology (Hoboken, N.J.) 73 (1) (2020)